Determinants of the severity of comorbid migraine in multiple sclerosis

Veronica Villani; Laura De Giglio; Giuliano Sette; Carlo Pozzilli; Marco Salvetti; Luca Prosperini

doi:10.1007/s10072-012-1119-5

Determinants of the severity of comorbid migraine in multiple sclerosis

Veronica Villani, Laura De Giglio, Giuliano Sette, Carlo Pozzilli, Marco Salvetti, Luca Prosperini

Istituto Regina Elena

Research output: Contribution to journal › Article › peer-review

Abstract

A high co-morbidity between multiple sclerosis (MS) and migraine has been reported, especially in young female patients affected by a relapsing-remitting (RR) course of MS. In this study, we aimed to elucidate the determinants of the severity of comorbid migraine in MS. Demographic, clinical and psychometric variables were collected from a cohort of 205 RR-MS patients regularly attending to an Italian outpatient MS Centre. Of them, 102 (49.8 %) were diagnosed as affected by comorbid migraine. About one-third of MS patients with comorbid migraine have asked the attending neurologist a specific anti-migraine treatment. Despite this, only few MS patients (10.8 %) reported a prior use of prophylactic drugs, and even fewer (2.9 %) took triptans as pain killers; these proportions were significantly lower when compared with those of a control group of 63 migraineurs subjects without MS (p

Original language	English
Pages (from-to)	1345-1353
Number of pages	9
Journal	Neurological Sciences
Volume	33
Issue number	6
DOIs	https://doi.org/10.1007/s10072-012-1119-5
Publication status	Published - Mar 23 2012

Keywords

Comorbidity
Disability
Migraine
Multiple sclerosis

ASJC Scopus subject areas

Clinical Neurology
Psychiatry and Mental health
Dermatology
Medicine(all)

Access to Document

10.1007/s10072-012-1119-5

Cite this

@article{e3eed55b515849b4814b898395593409,

title = "Determinants of the severity of comorbid migraine in multiple sclerosis",

abstract = "A high co-morbidity between multiple sclerosis (MS) and migraine has been reported, especially in young female patients affected by a relapsing-remitting (RR) course of MS. In this study, we aimed to elucidate the determinants of the severity of comorbid migraine in MS. Demographic, clinical and psychometric variables were collected from a cohort of 205 RR-MS patients regularly attending to an Italian outpatient MS Centre. Of them, 102 (49.8 %) were diagnosed as affected by comorbid migraine. About one-third of MS patients with comorbid migraine have asked the attending neurologist a specific anti-migraine treatment. Despite this, only few MS patients (10.8 %) reported a prior use of prophylactic drugs, and even fewer (2.9 %) took triptans as pain killers; these proportions were significantly lower when compared with those of a control group of 63 migraineurs subjects without MS (p",

keywords = "Comorbidity, Disability, Migraine, Multiple sclerosis",

author = "Veronica Villani and {De Giglio}, Laura and Giuliano Sette and Carlo Pozzilli and Marco Salvetti and Luca Prosperini",

year = "2012",

month = mar,

day = "23",

doi = "10.1007/s10072-012-1119-5",

language = "English",

volume = "33",

pages = "1345--1353",

journal = "Neurological Sciences",

issn = "1590-1874",

publisher = "Springer-Verlag Italia s.r.l.",

number = "6",

}

TY - JOUR

T1 - Determinants of the severity of comorbid migraine in multiple sclerosis

AU - Villani, Veronica

AU - De Giglio, Laura

AU - Sette, Giuliano

AU - Pozzilli, Carlo

AU - Salvetti, Marco

AU - Prosperini, Luca

PY - 2012/3/23

Y1 - 2012/3/23

N2 - A high co-morbidity between multiple sclerosis (MS) and migraine has been reported, especially in young female patients affected by a relapsing-remitting (RR) course of MS. In this study, we aimed to elucidate the determinants of the severity of comorbid migraine in MS. Demographic, clinical and psychometric variables were collected from a cohort of 205 RR-MS patients regularly attending to an Italian outpatient MS Centre. Of them, 102 (49.8 %) were diagnosed as affected by comorbid migraine. About one-third of MS patients with comorbid migraine have asked the attending neurologist a specific anti-migraine treatment. Despite this, only few MS patients (10.8 %) reported a prior use of prophylactic drugs, and even fewer (2.9 %) took triptans as pain killers; these proportions were significantly lower when compared with those of a control group of 63 migraineurs subjects without MS (p

AB - A high co-morbidity between multiple sclerosis (MS) and migraine has been reported, especially in young female patients affected by a relapsing-remitting (RR) course of MS. In this study, we aimed to elucidate the determinants of the severity of comorbid migraine in MS. Demographic, clinical and psychometric variables were collected from a cohort of 205 RR-MS patients regularly attending to an Italian outpatient MS Centre. Of them, 102 (49.8 %) were diagnosed as affected by comorbid migraine. About one-third of MS patients with comorbid migraine have asked the attending neurologist a specific anti-migraine treatment. Despite this, only few MS patients (10.8 %) reported a prior use of prophylactic drugs, and even fewer (2.9 %) took triptans as pain killers; these proportions were significantly lower when compared with those of a control group of 63 migraineurs subjects without MS (p

KW - Comorbidity

KW - Disability

KW - Migraine

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=84883519396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883519396&partnerID=8YFLogxK

U2 - 10.1007/s10072-012-1119-5

DO - 10.1007/s10072-012-1119-5

M3 - Article

C2 - 22644131

AN - SCOPUS:84883519396

VL - 33

SP - 1345

EP - 1353

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

IS - 6

ER -

Determinants of the severity of comorbid migraine in multiple sclerosis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this